Identification of novel loci for multiple myeloma when comparing with its precursor condition monoclonal gammopathy of unknown significance
Leukemia
.
2024 Feb;38(2):383-385.
doi: 10.1038/s41375-023-02078-6.
Epub 2023 Nov 2.
Authors
Christopher Staffi Buradagunta
1
,
Shahram Arsang-Jang
1
,
Ben Massat
1
,
Bicky Thapa
1
,
Victoria Patek
1
,
Anita D'Souza
1
,
Paul Auer
2
,
Raul Urrutia
3
,
Siegfried Janz
1
,
Binod Dhakal
1
,
Parameswaran Hari
1
,
Jing Dong
4
5
6
Affiliations
1
Division of Hematology Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
2
Division of Biostatistics, Institute for Health & Equity, and Cancer Center, Medical College of Wisconsin, Milwaukee, WI, USA.
3
Linda T. and John A. Mellowes Center for Genomic Sciences and Precision Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
4
Division of Hematology Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA. jidong@mcw.edu.
5
Linda T. and John A. Mellowes Center for Genomic Sciences and Precision Medicine, Medical College of Wisconsin, Milwaukee, WI, USA. jidong@mcw.edu.
6
Medical College of Wisconsin Cancer Center, Milwaukee, WI, USA. jidong@mcw.edu.
PMID:
37919604
DOI:
10.1038/s41375-023-02078-6
No abstract available
Publication types
Research Support, N.I.H., Extramural
MeSH terms
Humans
Monoclonal Gammopathy of Undetermined Significance* / genetics
Multiple Myeloma* / genetics
Paraproteinemias* / genetics
Grants and funding
K01 HL164972/HL/NHLBI NIH HHS/United States
K01 HL164972/HL/NHLBI NIH HHS/United States
UL1 TR001436/TR/NCATS NIH HHS/United States
R01 CA151354/CA/NCI NIH HHS/United States